Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Income from Continuing Operations (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Income from Continuing Operations for 4 consecutive years, with 3137466.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 5.75% to 3137466.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14909754.0 through Dec 2025, down 64.93% year-over-year, with the annual reading at 14909754.0 for FY2025, 64.93% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 3137466.0 at bioAffinity Technologies, up from 5051084.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 88052.0 in Q2 2022, with the low at 5051084.0 in Q3 2025.
  • Average Income from Continuing Operations over 4 years is 2502544.31, with a median of 2200581.5 recorded in 2023.
  • Peak annual rise in Income from Continuing Operations hit 53.43% in 2023, while the deepest fall reached 1876.3% in 2023.
  • Over 4 years, Income from Continuing Operations stood at 1674583.0 in 2022, then tumbled by 41.72% to 2373164.0 in 2023, then decreased by 25.02% to 2966897.0 in 2024, then decreased by 5.75% to 3137466.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 3137466.0, 5051084.0, and 4060787.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.